Get the Stockscreener App
0.649
5.10%
0.0315
After Hours:
.65
0.001
+0.15%
China Pharma Holdings Inc. stock is traded at $0.649, with a volume of 9,240.
It is up +5.10% in the last 24 hours and up +7.75% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$0.6175
Open:
$0.6497
24h Volume:
9,240
Relative Volume:
0.19
Market Cap:
$26.30M
Revenue:
$4.14M
Net Income/Loss:
$-3.19M
P/E Ratio:
-0.8687
EPS:
-0.7471
Net Cash Flow:
$11,000
1W Performance:
+4.68%
1M Performance:
+7.75%
6M Performance:
-65.84%
1Y Performance:
-55.85%
1-Day Range:
$0.5907
$0.6497
1-Week Range:
$0.5317
$0.6551
52-Week Range:
$0.5003
$2.5977
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.649 | 25.02M | 4.14M | -3.19M | 11,000 | -0.7471 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
120.76 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.66 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.61 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
577.58 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
Trading Recap: Does ALLT have strong EBITDA margins2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
Aug Sentiment: Why is Alexanders Inc stock going downProduct Launch & Weekly High Momentum Picks - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
US Market Recap: Can PBHC generate free cash flowLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Ascentage Pharma Group International (NASDAQ:AAPG) Raised to "Strong-Buy" at China Intl Cap - MarketBeat
Market Catalysts: Is China Pharma Holdings Incs ROE strong enough2026 Volume Leaders & High Conviction Trade Alerts - baoquankhu1.vn
Earnings Risk: Can China Pharma Holdings Inc expand its profit marginsVolume Spike & Low Drawdown Trading Strategies - baoquankhu1.vn
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison - Defense World
CUPR PE Ratio & Valuation, Is CUPR Overvalued - Intellectia AI
DRMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
China Pharma Holdings, Inc. (XQJ.DE) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
China Pharma Holdings, Inc. (XQJ.DE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
China Pharma Delays 10-K but Shows Narrowing Losses - The Globe and Mail
China Pharma Holdings 2026 Annual Report: Strategic Focus on Generic Drugs, Market Expansion, and Innovation in China’s Pharmaceutical Industry - Minichart
China Pharma Holdings Files For Non-Timely 10-K With US SEC - TradingView
China Pharma Holdings 10-K: Revenue $4.14M, Loss per Share $(0.74) - TradingView — Track All Markets
China Pharma (NYSE American: CPHI) details 2025 losses and China policy risks - Stock Titan
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Buy Signal: Can China Pharma Holdings Inc keep up with sector leadersBull Run & Trade Opportunity Analysis - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
China Pharma Holdings, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Risk Report: How does China Pharma Holdings Inc perform in inflationary periods2026 Growth vs Value & Capital Protection Trade Alerts - baoquankhu1.vn
China NT Pharma Group Announces Reduced Net Loss for 2025 After One-Off Non-Cash Gain – Profit Warning Update - Minichart
Market Outlook: How does China Pharma Holdings Inc perform in inflationary periodsForecast Cut & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Aug Technicals: Can China Pharma Holdings Inc expand into new marketsQuarterly Investment Review & Stepwise Trade Signal Implementation - baoquankhu1.vn
Jobs Data: Is China Pharma Holdings Incs ROE strong enough2026 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Drivers: Can China Pharma Holdings Inc keep up with sector leadersTrade Analysis Report & Low Volatility Stock Recommendations - baoquankhu1.vn
If You Invested $1,000 in China Pharma (CPHI) - Stock Titan
Quarterly Trades: How does China Pharma Holdings Inc perform in inflationary periodsMarket Sentiment Report & AI Enhanced Execution Alerts - baoquankhu1.vn
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative - simplywall.st
Market Outlook: Will China Pharma Holdings Inc be affected by tariffs2026 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback - simplywall.st
Investment Recap: How correlated is NCDL to the S P500Long Setup & Weekly Momentum Stock Picks - baoquankhu1.vn
Bearish Setup: How does China Pharma Holdings Inc perform in inflationary periods2026 Winners & Losers & Low Drawdown Investment Strategies - baoquankhu1.vn
Volume Recap: What are the analyst revisions for Amdocs LimitedIs CTEV stock a good investment in YEARProduct Launch & AI Based Buy and Sell Signals - baoquankhu1.vn
Can China Pharma Holdings Inc lead its sector in growth2026 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
Q4 and annual financial update released, Corbus Pharmaceuticals Holdings, Inc. outlines - Traders Union
Will Pony AI Inc. Depositary Receipt stock continue dividend increases2026 Support & Resistance & Reliable Intraday Trade Plans - Naître et grandir
How GreenTree Hospitality Group Ltd. American stock performs during market turbulencePortfolio Risk Report & Weekly Return Optimization Plans - Naître et grandir
Volume Report: Is Central Plains Bancshares Inc backed by strong institutional buyingRisk Management & Community Consensus Trade Alerts - baoquankhu1.vn
Is Southland Holdings Inc. Equity Warrant stock a dividend growth opportunityIPO Watch & Risk Controlled Daily Trade Plans - Naître et grandir
Fed Watch: Is China Pharma Holdings Incs ROE strong enoughJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
Trade Recap: Can China Pharma Holdings Inc expand into new marketsJuly 2025 Intraday Action & Community Consensus Trade Signals - baoquankhu1.vn
CPHI Earnings History & Surprises | EPS & Revenue Results | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
Form 10-KAnnual Reports - Stock Titan
China Pharma Expands R&D Portfolio With Patent Acquisition - TipRanks
Quarterly Risk: Can China Pharma Holdings Inc keep up with sector leadersJuly 2025 WrapUp & Fast Gain Stock Trading Tips - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
Naproxen Patches Market Growth Fueled by Shift from Oral Nsaids, Forecast to 2035News and Statistics - IndexBox
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):